Aldevron, L.l.c
Fargo, ND Part of Beckman Coulter, Inc.
- UEI
- GM49EPBCC4R7
- CAGE
- 3A5V3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Beckman Coulter, Inc. · Brea, CA
Z4DRFM3LMJB8
-
Parent
Beckman Coulter, Inc. · Brea, CA
Z4DRFM3LMJB8
- SAM.gov registration date
- Physical address
- 4055 41st Ave S, Fargo, ND 58104, USA
- Website
- aldevron.com
- Founded
- 1998
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$1 |
| FY2025 | $0 |
| FY2024 | $10,910 |
| FY2023 | -$37 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Children's Hospital Of Philadelphia | U01TR005355 | $275,238 | |
| The Children's Hospital Of Philadelphia | U01TR005355 | $200,000 |
Similar vendors
About the company
Aldevron, L.l.c. is a for-profit limited liability company and manufacturer of goods registered to receive awards from the U.S. federal government since August 21, 2002. The company specializes in providing biological products and services to support medical research and development efforts. Aldevron primarily supplies custom DNA plasmids, recombinant proteins, and other biological materials to federal agencies, particularly within the Department of Health and Human Services. As a subsidiary of Danaher Corporation, Aldevron has established itself as a key supplier for various research initiatives, particularly those related to vaccine development and infectious disease studies.
The company has received multiple prime contract awards from the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, both part of the National Institutes of Health. These contracts have involved the production and purification of custom DNA plasmids, blood products, and other biological materials essential for vaccine research, including studies on HIV and SIV (Simian Immunodeficiency Virus) in rhesus macaques. Specific products provided include recombinant SIV gp120 and DNA vectors, as well as plasmid purification, sequencing, and dispensing services. Aldevron has also participated in subcontract work related to stability studies and protocol extensions. The contract awards to Aldevron have typically been firm-fixed-price purchase orders, ranging in value from approximately $10,000 to $53,000, with no set-aside designations used. These contracts reflect Aldevron's crucial role in supporting cutting-edge biomedical research and vaccine development efforts within the federal government.
Quick answers
Is Aldevron, L.l.c registered in SAM.gov?
Yes. Aldevron, L.l.c's SAM.gov registration is active through April 1, 2027.
How much has Aldevron, L.l.c received in federal contracts?
Federal contracts obligated $10,871 to Aldevron, L.l.c in fiscal years 2023 through 2027.
What is Aldevron, L.l.c's most recent federal award?
Aldevron, L.l.c's most recent federal contract award is Blood product (75N91024P00152), from National Cancer Institute (NIH), on January 5, 2024.
On GovTribe
See Aldevron, L.l.c's full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors